Pliant Therapeutics Inc
PLRX
Market Cap$103.74M
Close$
$0.18
87.6% downside
Current Fair Value
87.6% downsideOvervalued by 87.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $103.74 Million |
|---|---|
| Enterprise Value | $92.75 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.47 |
| Beta | 1.47 |
| Outstanding Shares | 60,538,639 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.49 |
|---|---|
| PEG | -1.24 |
| Price to Sales | - |
| Price to Book Ratio | 0.29 |
| Enterprise Value to Revenue | 19.16 |
| Enterprise Value to EBIT | -0.42 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.65 |
| Debt to Equity | 0.2 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Pliant Therapeutics Inc
CEO: Bernard Coulie